International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Q10 Pharmaceutical Quality System." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance describes a model for an effective quality management system for the pharmaceutical industry, referred to as the Pharmaceutical Quality System. The guidance is intended to provide a comprehensive approach to an effective pharmaceutical quality system that is based on International Organization for Standardization (ISO) concepts, includes applicable good manufacturing practice (GMP) regulations and complements ICH guidances on "Q8 Pharmaceutical Development" and "Q9 Quality Risk Management."
D003226:Congresses as Topic; D017277:Drug Approval; D004345:Drug Industry / Q000592:standards*; D005060:Europe; D017408:Guidelines as Topic / Q000592:standards*; D006801:Humans; D007390:International Agencies; D007391:International Cooperation; D007564:Japan; D011785:Quality Assurance, Health Care / Q000592:standards*; D011786:Quality Control; D014481:United States; D014486:United States Food and Drug Administration